These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 18071976)

  • 21. Pediatric HIV type 1 vaccine trial acceptability among mothers in Kenya.
    Farquhar C; John-Stewart GC; John FN; Kabura MN; Kiarie JN
    AIDS Res Hum Retroviruses; 2006 Jun; 22(6):491-5. PubMed ID: 16796522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. European Union and EDCTP strategy in the global context: recommendations for preventive HIV/AIDS vaccines research.
    Lehner T; Hoelscher M; Clerici M; Gotch F; Pedneault L; Tartaglia J; Gray C; Mestecky J; Sattentau Q; van de Wijgert J; Toure C; Osmanov S; Schmidt RE; Debre P; Romaris M; Hoeveler A; Di Fabio S
    Vaccine; 2005 Dec; 23(48-49):5551-6. PubMed ID: 16153752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Caveats and pitfalls associated with researching community engagement in the context of HIV vaccine trials.
    Kagee A; De Wet A; Kafaar Z; Lesch A; Swartz L; Newman PA
    J Health Psychol; 2020 Jan; 25(1):82-91. PubMed ID: 29243520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adolescents and HIV vaccine trials: what are the clinical trial site issues?
    Bekker LG; Jaspan H; McIntyre J; Wood R; Gray G
    J Int Assoc Physicians AIDS Care (Chic); 2005 Dec; 4(4):93-7. PubMed ID: 16533798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting increased condom use with main partners: potential approaches to intervention.
    Bowen AM
    Drugs Soc (New York); 1996; 9(1-2):57-74. PubMed ID: 12348011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Development of HIV vaccines].
    Shibata R
    Nihon Rinsho; 2002 Apr; 60(4):790-7. PubMed ID: 11968790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [10 years' research in the social sciences on AIDS in Burkina Faso. Elements for prevention].
    Desclaux A
    Sante; 1997; 7(2):127-34. PubMed ID: 9273119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An extended model of reasoned action to understand the influence of individual- and network-level factors on African Americans' participation in HIV vaccine research.
    Frew PM; Archibald M; Diallo DD; Hou SI; Horton T; Chan K; Mulligan MJ; del Rio C
    Prev Sci; 2010 Jun; 11(2):207-18. PubMed ID: 20012200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scientific and policy challenges to development of an AIDS vaccine.
    Berkley SF; Koff WC
    Lancet; 2007 Jul; 370(9581):94-101. PubMed ID: 17617277
    [No Abstract]   [Full Text] [Related]  

  • 30. Participation of South African youth in the design and development of AIDS photocomics. 1997-98.
    Toroyan T; Reddy PS
    Int Q Community Health Educ; 2005-2006; 25(1-2):149-63. PubMed ID: 17686700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accelerating the development and future availability of HIV-1 vaccines: why, when, where, and how?
    Esparza J; Bhamarapravati N
    Lancet; 2000 Jun; 355(9220):2061-6. PubMed ID: 10885368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Community preparedness for HIV vaccine trials in the Democratic Republic of Congo.
    Olin J; Kokolamami J; Lepira FB; Mwandagalirwa K; Mupenda B; Ndongala ML; Maman S; Bollinger R; Nachega J; Mokili J
    Cult Health Sex; 2006; 8(6):529-44. PubMed ID: 17050384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The health belief model. A theoretical approach to the prevention of AIDS].
    Soto Mas F; Lacoste Marín JA; Papenfuss RL; Gutiérrez León A
    Rev Esp Salud Publica; 1997; 71(4):335-41. PubMed ID: 9490188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Provision of HIV treatment in HIV preventive vaccine trials: a developing country perspective.
    Slack C; Stobie M; Milford C; Lindegger G; Wassenaar D; Strode A; Ijsselmuiden C
    Soc Sci Med; 2005 Mar; 60(6):1197-208. PubMed ID: 15626517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV vaccine trial preparedness among Spanish-speaking Latinos in the US.
    Brooks RA; Newman PA; Duan N; Ortiz DJ
    AIDS Care; 2007 Jan; 19(1):52-8. PubMed ID: 17129857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How to sell safer sex.
    Overs C
    AIDS Action; 1991 Sep; (15):2-3. PubMed ID: 12284682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Community participation in AIDS vaccine trials: empowerment or science?
    Swartz L; Kagee A
    Soc Sci Med; 2006 Sep; 63(5):1143-6. PubMed ID: 16707200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unsafe sex: decision-making biases and heuristics.
    Kaplan BJ; Shayne VT
    AIDS Educ Prev; 1993; 5(4):294-301. PubMed ID: 8297709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Executive summary and recommendations from WHO/UNAIDS and AAVP consultation on: 'The inclusion of adolescents in HIV vaccine trials', 16-18 March 2006 in Gaborone, Botswana.
    ; Osmanov S
    AIDS; 2007 Sep; 21(14):W1-10. PubMed ID: 17721089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perceptions of a community sample about participation in future HIV vaccine trials in south India.
    Nyamathi AM; Suhadev M; Swaminathan S; Fahey JL
    AIDS Behav; 2007 Jul; 11(4):619-27. PubMed ID: 17016758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.